產品詳情
簡單介紹：
Anti-NOD26/NLRX1抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-NOD26/NLRX1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-NOD26/NLRX1
Cat. Number:
Anti-NOD26/NLRX1抗體KL-8511R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The leucine-rich (LRR) repeat is a 20-30 amino acid motif that forms a hydrophobic ?/∫ horseshoe fold, allowing it to accommodate several leucine residues within a tightly packed core. All LRR repeats contain a variable Anti-NOD26/NLRX1抗體segment and a highly conserved segment, the latter of which accounts for 11 or 12 residues of the entire LRR motif. NOD9, also known as NLRX1, NOD26 or NOD5, is a 975 amino acid outer mitochondrial membrane protein that contains one NACHT domain and four LRR repeats. Expressed at high levels in heart, muscle and mammary gland, NOD9 plays a role in antiviral signaling, specifically via inhibition of virus-induced helicases, thereby acting as a negative regulator of antiviral responses. Two isoforms of NOD9 exist due to alternative splicing events.
Also known as:
Caterpiller protein 11.3; CLR11.3; DLNB26; NLR family member X1 NLR family, X1 Nlrx1 NLRX1_HUMAN NOD-like Anti-NOD26/NLRX1抗體receptor X1 NOD26 NOD5 NOD9 Nucleotide-binding oligomerization domain protein 26 Nucleotide-binding oligomerization domain protein 5 Nucleotide-binding oligomerization domain protein 9 nucleotide-binding oligomerization domain, leucine rich repeat containing X1 Protein Caterpiller 11.3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated Anti-NOD26/NLRX1抗體synthetic peptide derived from human NLRX1/NOD26/NOD9.
●
Predicted Molecular Weight: 98kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-NOD26/NLRX1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-NOD26/NLRX1抗體
Optimal working dilutions must be determined by the end user.
